Patents for A61P 35 - Antineoplastic agents (221,099)
01/2007
01/03/2007CN1889969A Methods for treating prostate cancer with herbal compositions
01/03/2007CN1889962A Pharmaceutical uses of bisphosphonates
01/03/2007CN1889958A Methods for suppressing an immune response or a treating a proliferative disorder
01/03/2007CN1889952A Combination of (a) n-[5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2methylphenyl]-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof
01/03/2007CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase
01/03/2007CN1889950A The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person
01/03/2007CN1889946A CHP-gemcitabin combined agent and use thereof as anti-tumoural active substances
01/03/2007CN1889945A Use of CHP as an inhibitor of glutathione s-transferases and collagen iv
01/03/2007CN1887901A Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
01/03/2007CN1887899A Amino alcohol as chemical modifier for ursolic acid
01/03/2007CN1887898A Amino acid as chemical modifier for ursolic acid
01/03/2007CN1887896A Tumor inhibiting antisense nucleotide
01/03/2007CN1887878A Triazinyl nitroxide and its synthesis and use
01/03/2007CN1887877A Thirteen-eliment nanometer RE anticancer compound and its prepn and application
01/03/2007CN1887876A Nanometer RE heterocyclic anticancer compound and its prepn and application
01/03/2007CN1887717A Nanometer binary anticancer RE compound and its prepn and application
01/03/2007CN1887338A Prepn process and quality control technology of Shenlian granule
01/03/2007CN1887335A Tumor-inhibiting anticancer oral liquid
01/03/2007CN1887319A Anticancer scorpion venom capsule
01/03/2007CN1887296A Method of inducing antitumor immunity and its application in preparing medicine
01/03/2007CN1887292A Soft lentinan capsule and its prepn
01/03/2007CN1887291A Clorfarabine composition
01/03/2007CN1887281A Application of gallate in preparing anticancer medicine
01/03/2007CN1887269A Slow released anticancer injection containing bendamustine and its synergist
01/03/2007CN1887268A Slow released anticancer injection
01/03/2007CN1887267A Slow released anticancer prepn with angiogenesis inhibitor and bendamustine
01/03/2007CN1887266A Slow released compound anticancer prepn
01/03/2007CN1887265A Slow released anticancer prepn
01/03/2007CN1887264A Slow released compound anticancer prepn containing bendamustine
01/03/2007CN1887262A Slow released anticancer medicine injection containing bendamustine and its synergist
01/03/2007CN1887261A Slow released compound anticancer injection containing bendamustine
01/03/2007CN1887260A Slow released compound anticancer injection containing clorfarabine
01/03/2007CN1887259A Slow released compound anticancer prepn containing clorfarabine
01/03/2007CN1887258A Slow released compound anticancer injection containing clorfarabine
01/03/2007CN1293192C Immunoregulation polynucleotide and using method thereof
01/03/2007CN1293088C Stabilization of amrubicin hydrochloride
01/03/2007CN1293076C Activator for peroxisome proliferator-activated receptor delta
01/03/2007CN1293065C Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
01/03/2007CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
01/03/2007CN1293061C Novel branched substituted amino derivatives of 3-amino-1-phemyl-1H-[1,2,4]triazo, methods for producing them and pharmaceutica compositions containing them
01/03/2007CN1293051C Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer
01/03/2007CN1293042C Aromatic amino acid derivates and medicinal compositions
01/03/2007CN1293034C New gamma selective retinoids
01/03/2007CN1292797C Immune regulator, immune regulator food and immune regulator fodder
01/03/2007CN1292796C Controlled release composition and method of producing the same
01/03/2007CN1292790C Chinese traditional medicine for preventing and curing cardiovascular and cerebrovascular diseases
01/03/2007CN1292757C Chinese medicine for curing tumor and its production method
01/03/2007CN1292751C Imiquimod or its derivative liposome for local skin and its preparing method and use
01/03/2007CN1292750C Total alkaloid composition from plant and its pharmaceutical preparation
01/03/2007CN1292745C The treatment of respiratory diseases
01/02/2007USRE39456 Radioactive embolizing compositions
01/02/2007US7157604 Selective estrogen receptor modulators
01/02/2007US7157596 Inhibitors of serine protease activity of matriptase or MTSP1
01/02/2007US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents
01/02/2007US7157570 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
01/02/2007US7157557 Generation of preferential genetically engineered protein; obtain cells, transform with vector containing protein, express vector, recover protein
01/02/2007US7157552 Mutant trichosanthin
01/02/2007US7157498 Diamines having a CaSR modulating activity
01/02/2007US7157487 Vla-4 inhibitors
01/02/2007US7157477 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
01/02/2007US7157474 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound
01/02/2007US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
01/02/2007US7157466 Quinazoline ditosylate salt compounds
01/02/2007US7157465 Adenine derivatives
01/02/2007US7157458 Bifunctional energy-reversible acyl-compositions
01/02/2007US7157457 Compounds useful in the treatment of inflammatory diseases
01/02/2007US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer
01/02/2007US7157453 Urea substituted imidazoquinolines
01/02/2007US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine
01/02/2007US7157446 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
01/02/2007US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells
01/02/2007US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
01/02/2007US7157432 Tetraphenylbacteriochlorin derivatives and compositions containing the same
01/02/2007US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases
01/02/2007US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
01/02/2007US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration
01/02/2007US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders
01/02/2007US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor
01/02/2007US7157238 Identifying micrometastsized tissue/masses using double immunoglobulin labeling; immunodiagnostics and cancer detection
01/02/2007US7157092 3-(3-dodecanoyloxytetradecanoylamino) 9-(3-hydroxytetradecanoylamino)-4-oxo-5-azadecan-1,10-diol, 1,10-bis-(dihydrogenphosphate) or its addition salts; treatment of diseases related to a deficiency in the immune defense system or an overexpression of immune responses, cancer therapy
01/02/2007US7157091 Endosomal targeting signal contains an endosomal targeting portion of human invariant chain Ii or LAMP-1.
01/02/2007US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
01/02/2007CA2436275C Polymeric delivery formulations of leuprolide with improved efficacy
01/02/2007CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
01/02/2007CA2368615C Thiadiazolyl urea or thiourea derivatives for antiviral treatment
01/02/2007CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
01/02/2007CA2315909C Novel acronycine derivatives, preparation method and pharmaceutical compositions
01/02/2007CA2283255C Use of r-nsaid's for the prevention of alzheimer's disease
01/02/2007CA2274464C Ketobenzamides as calpain inhibitors
01/02/2007CA2237059C Targeted adenovirus vectors
01/02/2007CA2218892C Diaromatic propynyl or dienyl compounds
01/02/2007CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors
01/02/2007CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
12/2006
12/28/2006WO2006138507A1 Use of sanglifehrin in hcv
12/28/2006WO2006138427A2 Combretastatin analogs with tubulin binding activity
12/28/2006WO2006138180A1 Tubulin inhibitor and process for its preparation
12/28/2006WO2006138155A1 Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
12/28/2006WO2006138059A2 Treatment of autoimmune disorders with a neurotoxin
12/28/2006WO2006137953A1 Phosphono-pent-2-en-1-yl nucleosides and analogs
12/28/2006WO2006137789A1 Quinoline 3 -sulfonate esters as NK3 receptor modulators